TheraCryf plc
Climate Impact & Sustainability Data (2024-01 to 2024-09)
Reporting Period: 2024-01 to 2024-09
Environmental Metrics
Climate Goals & Targets
Environmental Challenges
- Sudden passing of Chair of the Board, Dr Sue Foden.
- Ongoing dispute with partner Stalicla SA on optimal design of the Phase 2 study in autism spectrum disorder.
Mitigation Strategies
- Amicable discussions continue with partner Stalicla SA to resolve the dispute.
- The company is better positioned to execute on its business model despite the loss of Dr Foden.